Cargando…
Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens
Inducing humoral and cytotoxic mucosal immunity at the sites of pathogen entry has the potential to prevent the infection from getting established. This is different from systemic vaccination, which protects against the development of systemic symptoms. The field of mucosal vaccination has seen fewe...
Autores principales: | Dotiwala, Farokh, Upadhyay, Arun K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10611113/ https://www.ncbi.nlm.nih.gov/pubmed/37896988 http://dx.doi.org/10.3390/vaccines11101585 |
Ejemplares similares
-
A comprehensive review of BBV152 vaccine development, effectiveness, safety, challenges, and prospects
por: Dotiwala, Farokh, et al.
Publicado: (2022) -
Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
por: Drag, Selina, et al.
Publicado: (2023) -
Adenoviral-vectored next-generation respiratory mucosal
vaccines against COVID-19
por: Afkhami, Sam, et al.
Publicado: (2023) -
Towards the future exploration of mucosal mRNA vaccines against emerging viral diseases; lessons from existing next-generation mucosal vaccine strategies
por: Hameed, Sodiq A., et al.
Publicado: (2022) -
Mucosal Vaccination via the Respiratory Tract
por: Hellfritzsch, Marie, et al.
Publicado: (2019)